Finance

Lists
Why is 128940 down 2,64%?
Dive Deeper
128940:KRX
Hanmi Pharm Co Ltd
387 000,00 ₩
-2,64%
(-10 500,00) 1D
19 հոկ, 15:05:00 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 128940...
Open
389 500 ₩
High
394 500 ₩
Low
370 000 ₩
Mkt. cap
4,96 տրլն
Avg. vol.
124,40 հզր
Volume
92,70 հզր
Dividend
0,52%
Quarterly dividend
500 ₩
Ex-dividend date
30 մրտ, 2026 թ.
P/E ratio
22,63
52-wk high
647 000 ₩
52-wk low
302 000 ₩
EPS
17 100 ₩
Shares outstanding
12,81 մլն
No. of employees
2 հզր
Open
389 500 ₩
High
394 500 ₩
Low
370 000 ₩
Mkt. cap
4,96 տրլն
Avg. vol.
124,40 հզր
Volume
92,70 հզր
Dividend
0,52%
Quarterly dividend
500 ₩
Ex-dividend date
30 մրտ, 2026 թ.
P/E ratio
22,63
52-wk high
647 000 ₩
52-wk low
302 000 ₩
EPS
17 100 ₩
Shares outstanding
12,81 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Profile
Hanmi Pharm Co., Ltd. is a South Korean pharmaceutical company that is headquartered in Seoul. Wikipedia
About Hanmi Pharm Co Ltd
CEO-
Employees2,34 հզր
Founded1973
Headquarters-
Sector-
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
362,35 մլրդ
432,96 մլրդ
392,93 մլրդ
467,25 մլրդ
Cost of goods sold
156,75 մլրդ
172,48 մլրդ
175,64 մլրդ
164,04 մլրդ
Cost of revenue
156,75 մլրդ
172,48 մլրդ
175,64 մլրդ
164,04 մլրդ
Research and development expenses
54,65 մլրդ
51,66 մլրդ
57,12 մլրդ
52,08 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
95,88 մլրդ
125,55 մլրդ
106,52 մլրդ
120,03 մլրդ
Operating expense
153,33 մլրդ
205,73 մլրդ
171,55 մլրդ
179,72 մլրդ
Total operating expenses
310,08 մլրդ
378,22 մլրդ
347,19 մլրդ
343,76 մլրդ
Operating income
52,27 մլրդ
54,74 մլրդ
45,74 մլրդ
123,49 մլրդ
Other non operating income
-1,73 մլրդ
664,20 մլն
2,62 մլրդ
-4,88 մլրդ
EBT including unusual items
52,26 մլրդ
58,49 մլրդ
55,38 մլրդ
120,14 մլրդ
EBT excluding unusual items
51,55 մլրդ
57,99 մլրդ
55,26 մլրդ
119,61 մլրդ
Income tax expense
6,85 մլրդ
4,43 մլրդ
4,30 մլրդ
36,06 մլրդ
Effective tax rate
13,10%
7,58%
7,76%
30,01%
Other operating expenses
-
-
-
-
Net income
40,13 մլրդ
48,12 մլրդ
45,49 մլրդ
83,31 մլրդ
Net profit margin
11,07%
11,11%
11,58%
17,83%
Earnings per share
-
-
-
-
Interest and investment income
1,67 մլրդ
2,51 մլրդ
2,62 մլրդ
2,77 մլրդ
Interest expense
-3,94 մլրդ
-3,65 մլրդ
-3,41 մլրդ
-3,35 մլրդ
Net interest expenses
-2,27 մլրդ
-1,14 մլրդ
-783,67 մլն
-588,23 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
76,84 մլրդ
80,03 մլրդ
70,44 մլրդ
148,58 մլրդ
Gain or loss from assets sale
-13,32 մլն
-39,36 մլն
3,68 մլն
40,66 մլն
AI content may include mistakes. Learn more
Google Apps